Skip to main content
. 2021 Aug 4;28:18. doi: 10.1186/s40709-021-00149-2

Fig. 16.

Fig. 16

Active site residues & drug binding motifs of NSP13. a, b Position of active site residues and drug binding motifs in surface presentation. 478-Amprenavir; 017-Darunavir; RIM Rimantadine, ROC Saquinavir